OCULUS INNOVATIVE SCIENCES, INC.

Company

Sonoma Pharmaceuticals, Inc.

Filed

March 7, 2012

Period of Report

March 6, 2012

Accession Number

0001019687-12-000829

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →